Updated Analysis,Peptide Therapeutics Market size is growing with a CAGR of 6.8% in the prediction period

The global peptides market is experiencing robust growth, driven by significant advancements in peptide therapeutics and the expanding applications of peptides across various industries. This dynamic sector, which encompasses peptide synthesis and the production of peptide API CMOs and peptide CDMOs, is witnessing substantial investment and innovation, promising continued expansion in the coming years.

Peptide therapeutics represent a cornerstone of the global peptides market. These molecules offer a high degree of specificity and potency in targeting diseases, making them attractive alternatives to traditional small-molecule drugs. The global peptide therapeutics market was valued at USD 88.7 billion in 2025 and is on a trajectory to reach significant valuations. Projections indicate that this segment is projected to reach $157.5 billion by 2028, with various estimates suggesting further growth. For instance, some reports indicate the global peptide therapeutics market is projected to exceed $60 billion by the year 2026, while others forecast it to reach USD 334.95 billion by 2034, expanding at a compound annual growth rate (CAGR) of 10.91% during the forecast period of 2026-2034. The market was estimated at USD 46.4 billion in 2024 and is expected to grow from USD 49.7 billion in 2025 to USD 100 billion by 2034. Another projection places the global peptide therapeutics market size at USD 64.3 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031. The market is calculated at USD 54.57 billion in 2026 and is expected to reach around USD 81.5 billion by 2034. Furthermore, the global peptide therapeutics market is valued at approximately USD 46 billion, driven by the rising prevalence of chronic diseases and advancements in peptide technology.

The peptide synthesis market is another critical component of the overall global peptides market. This segment focuses on the creation of peptides for research, diagnostic, and therapeutic purposes. The peptide synthesis market was valued at USD 678.12 million in 2025 and is anticipated to reach USD 1,438.78 million by 2035. Another report states the peptide synthesis market size was over USD 5.8 billion in 2025 and is estimated to reach USD 12.2 billion by the end of 2035. The global peptide synthesis market size was USD 667.26 million in 2024 and is projected to grow from USD 750.66 million in 2025 to USD 1926.05 million by 2035. The Global Peptide Synthesis Market was valued at USD 4.70 Billion in 2022 and is expected to reach USD 8.82 Billion by 2030, growing at a CAGR of 8.2%. The peptide synthesis market worth USD 1.9 billion in 2026 is growing at a CAGR of 6.39% to reach USD 2.59 billion by 2031.

The global GMP peptides market is a specialized segment focusing on Good Manufacturing Practice (GMP) compliant peptides, essential for pharmaceutical applications. The global GMP peptides market size was valued at USD 1.3 billion in 2024 and is predicted to hit around USD 2.9 billion by 2034, indicating a significant growth trajectory.

The peptide API CMO market and peptide CDMO market are crucial for the outsourcing of peptide manufacturing. The peptide API CMO market is estimated to reach US$ 3283.0 billion by 2032, growing at a CAGR of 7.2% across the forecast period of 2026 to 2032. The global peptide CDMO market size is estimated at USD 5.51 Billion in 2026, set to expand to USD 29.15 Billion by 2035, growing at an impressive CAGR of 20.3%.

The global catalog peptides market also plays a vital role, providing a wide array of peptides for research and development. The Global Catalog Peptides Market Size is projected to reach USD 9.91 Billion in 2025 to USD 76.8 Billion by 2035 with a CAGR of 22.72% forecast for the period 2026–2035.

Several factors are contributing to the expansion of the global peptides market. These include the increasing prevalence of chronic diseases, advancements in protein engineering and production technologies, a strong clinical pipeline for peptide-based